Paul LaViolette is a Managing Partner & COO at SV Health Investors with over 35 years in medical technology. He previously held leadership roles at Boston Scientific and other medical device firms.








At firms with a similar stage, sector and check size.





One email when Paul's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckPaul LaViolette is a Managing Partner & COO at SV Health Investors with over 35 years in medical technology. He previously held leadership roles at Boston Scientific and other medical device firms.
SV Health Investors has not reported a check size. It invests at pre-seed, seed, series a, series b.
A warm intro from a founder SV Health Investors backed works best.
marketing and general management positions at CR Bard; Chief Operating Officer; Group President, Cardiovascular; President, Cardiology; Group President, Endosurgery; President, International at Boston Scientific; Kendall (Medtronic); CR Bard; Chief Operating Officer at Boston Scientific (BSC).
Last updated 2026-10-15. Is this you? Ask for a correction.